Form 13-F position report

BIOTE CORP CL A

Reported by WELLS FARGO & COMPANY MN

BTMD CUSIP 090683103 Manager CIK 0000072971

Reported 4,140 shares, up 959 (30.1%) from the prior quarter.

Reported value 25.6%; share count 30.1% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q4 2023
Shares 4,140 Quarter-end amount reported
Reported value $20,452 Fair value at quarter end
Consecutive quarters held 5 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 164
2023-03-31 347
2023-06-30 37809
2023-09-30 16287
2023-12-31 20452
2024-03-31 27451
2024-06-30 65706
2024-09-30 47424
2024-12-31 78746
2025-03-31 43390
2025-06-30 74893
2025-09-30 63111
2025-12-31 84406
2026-03-31 14348
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for BIOTE CORP CL A held by WELLS FARGO & COMPANY MN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -10,628 (-100.0%) 0 $0 2026-08-14
Q1 2026 Reduced 10,628 -21,836 (-67.3%) < 0.01% $14,348 2026-05-11
Q4 2025 Added 32,464 +11,427 (54.3%) < 0.01% $84,406 2026-02-13
Q3 2025 Added 21,037 +2,407 (12.9%) < 0.01% $63,111 2025-11-13
Q2 2025 Added 18,630 +5,600 (43.0%) < 0.01% $74,893 2025-08-14
Q1 2025 Added 13,030 +288 (2.3%) < 0.01% $43,390 2025-05-13
Q4 2024 Added 12,742 +4,243 (49.9%) < 0.01% $78,746 2025-02-13
Q3 2024 Reduced 8,499 -297 (-3.4%) < 0.01% $47,424 2024-11-13
Q2 2024 Added 8,796 +4,063 (85.8%) < 0.01% $65,706 2024-08-13
Q1 2024 Added 4,733 +593 (14.3%) < 0.01% $27,451 2024-05-10
Q4 2023 Added 4,140 +959 (30.1%) < 0.01% $20,452 2024-02-09
Q3 2023 Reduced 3,181 -2,412 (-43.1%) < 0.01% $16,287 2023-11-13
Q2 2023 Added 5,593 +5,537 (9887.5%) < 0.01% $37,809 2023-08-15
Q1 2023 Added 56 +12 (27.3%) < 0.01% $347 2023-05-12
Q4 2022 New 44 +44 (0.0%) < 0.01% $164 2023-02-13

Who else reported the position

60 managers reported BIOTE CORP CL A for Q4 2023.

Managers reporting BIOTE CORP CL A in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
325 CAPITAL LLC Unchanged 3,766,666 0 9.22% $18,607,330 4 qtrs
Bandera Partners LLC Added 1,832,732 +127,410 3.0% $9,053,696 3 qtrs
VANGUARD GROUP INC Added 1,419,529 +394,991 < 0.01% $7,012,473 4 qtrs
WASATCH ADVISORS INC Reduced 1,072,781 -157,097 0.03% $5,299,538 6 qtrs
BlackRock Inc Added 972,597 +237,650 < 0.01% $4,804,630 3 qtrs
Boston Partners Reduced 829,927 -61,091 < 0.01% $4,099,840 4 qtrs
SW Investment Management LLC Added 675,000 +22,651 1.15% $3,334,500 2 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 472,190 +143,394 < 0.01% $2,333,159 4 qtrs
STATE STREET CORPORATION Added 255,279 +12,900 < 0.01% $1,261,078 3 qtrs
Kent Lake Capital LLC Reduced 177,210 -1,107,087 0.34% $875,417 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 09, 2024
Filing type
13F-HR
Position type
CLASS A COM

Voting authority reported

Sole
4,140
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.